@entity1893 ( @entity1893 ) is a heterogeneous family of @entity5 , with treatment modalities including chemotherapy, surgery, and radiotherapy. Because the role of surgery in @entity1893 remains disputed, this study aims to assess the impact of operative resection on survival. We used a pathology database to identify all cases of @entity1893 diagnosed at a single academic-affiliated medical center from 1988 to 2013. Demographic and clinical data were abstracted from the medical record. We summarized the clinical courses of @entity1 with @entity1893 and then performed a survival analysis to compare overall and disease-free survival, stratified by demographic and clinical variables. We identified 33 @entity1 diagnosed with @entity1893 during the study period. Of 29 who subsequently received treatment at the institution, 15 initially underwent chemotherapy, 10 underwent surgical resection, and 4 underwent surgery for other reasons such as diagnosis without resection or management of disease complications. Three @entity1 suffered surgical complications and two of these @entity1 died. We found no difference in overall survival between @entity1 receiving surgical resection and @entity1 managed initially with chemotherapy. This case series supports a continued role for surgical resection in the management of @entity1 with @entity1893 , though anticipated benefits should be weighed against the risk of complications.

The Role of Surgery in the Clinical Management of Primary XXXX .

@entity1893 :: ('MESH:D008228', 'Disease') :: ['PGINHL', "Primary gastrointestinal non-Hodgkin's lymphoma"] @entity1 :: ('9606', 'Species') :: ['patients'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors']
@entity1893 :: (MESH:D008228,Disease) :: ['Gastrointestinal Non-Hodgkin's Lymphoma']
